NUTEX HEALTH INC. (NUTX)

189.25 -2.40% (-4.65)

Over 5Y: +1069109.0%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 000 4 000 6 000
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 267.8M Q3 '25 — Operating Cash Flow: 99.5M Q3 '25 — Free Cash Flow: 99.2M Q3 '25 — Net Income: 55.4M Q4 '25 — Revenue: 151.7M Q4 '25 — Operating Cash Flow: 70.4M Q4 '25 — Free Cash Flow: 69M Q4 '25 — Net Income: 11.8M Q1 '26 — Revenue: 216.5M Q1 '26 — Operating Cash Flow: 75.5M Q1 '26 — Free Cash Flow: 74.3M Q1 '26 — Net Income: 46.8M Q2 '26 — Revenue: 210.8M Q2 '26 — Operating Cash Flow: 34.2M Q2 '26 — Free Cash Flow: 31.7M Q2 '26 — Net Income: 65.8M 0 60M 120M 180M 240M 300M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

8.0
ROIC 57.0%
Oper. margin 43.0%
OE margin 19.7%
SBC / sales 12.7%
Accruals -10.3%
FCF margin 32.4%
OCF margin 33.0%
ROA 18.7%
ROCE 43.0%
ROE 45.6%
Gross margin 51.3%
OCF / EBIT 0.77×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
Segment HHI 0.93 HHI
RPO / sales —
RPO growth —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.1
ND/EBITDA —
Debt payback 0.4 yr
Payout 0.0%
Quick ratio 5.0×
Cash / Debt 0.65×
F-score 7.0 pts
Net debt / Eq 0.28×
Debt / Eq 0.8×
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.8
Sales CAGR 4Y +27.5%
Sales/sh Y/Y -13.1%
EBIT Y/Y +52.9%
EPS Y/Y +159.1%
Sales Q/Q -13.6%
Shares change +23.0%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.